HK1127917A1 - Imidazo [1,2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands - Google Patents
Imidazo [1,2-b] pyridazines, their processes of preparation and their use as gaba receptor ligandsInfo
- Publication number
- HK1127917A1 HK1127917A1 HK09104968.1A HK09104968A HK1127917A1 HK 1127917 A1 HK1127917 A1 HK 1127917A1 HK 09104968 A HK09104968 A HK 09104968A HK 1127917 A1 HK1127917 A1 HK 1127917A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyridazines
- imidazo
- processes
- preparation
- receptor ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06111899A EP1845098A1 (de) | 2006-03-29 | 2006-03-29 | Imidazo[1,2-b]pyridazinen, deren Herstellungverfahren und ihre Verwendung als GABA Rezeptor Liganden |
PCT/EP2007/052988 WO2007110437A1 (en) | 2006-03-29 | 2007-03-28 | Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1127917A1 true HK1127917A1 (en) | 2009-10-09 |
Family
ID=36323447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09104968.1A HK1127917A1 (en) | 2006-03-29 | 2009-06-03 | Imidazo [1,2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands |
Country Status (23)
Country | Link |
---|---|
US (2) | US8153789B2 (de) |
EP (2) | EP1845098A1 (de) |
JP (1) | JP5091944B2 (de) |
KR (1) | KR20090008275A (de) |
CN (1) | CN101448831B (de) |
AR (1) | AR060212A1 (de) |
AT (1) | ATE471325T1 (de) |
AU (1) | AU2007231362B2 (de) |
BR (1) | BRPI0709207A2 (de) |
CA (1) | CA2647116C (de) |
CY (1) | CY1111211T1 (de) |
DE (1) | DE602007007203D1 (de) |
DK (1) | DK2010536T3 (de) |
ES (1) | ES2347182T3 (de) |
HK (1) | HK1127917A1 (de) |
MX (1) | MX2008012274A (de) |
NO (1) | NO20084375L (de) |
PL (1) | PL2010536T3 (de) |
PT (1) | PT2010536E (de) |
RU (1) | RU2486188C9 (de) |
SI (1) | SI2010536T1 (de) |
TW (1) | TWI403512B (de) |
WO (2) | WO2007110437A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2555263A1 (en) * | 2004-02-12 | 2005-09-01 | Neurogen Corporation | Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands |
US8217177B2 (en) | 2006-07-14 | 2012-07-10 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
US8198448B2 (en) | 2006-07-14 | 2012-06-12 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
PE20121506A1 (es) | 2006-07-14 | 2012-11-26 | Amgen Inc | Compuestos triazolopiridinas como inhibidores de c-met |
FR2918061B1 (fr) * | 2007-06-28 | 2010-10-22 | Sanofi Aventis | Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique. |
US20100216994A1 (en) * | 2007-10-30 | 2010-08-26 | Nihon Medi-Physics Co., Ltd. | Use of novel compound having affinity for amyloid, and process for production of the same |
US7868001B2 (en) * | 2007-11-02 | 2011-01-11 | Hutchison Medipharma Enterprises Limited | Cytokine inhibitors |
US8492379B2 (en) | 2007-12-21 | 2013-07-23 | The University Of Sydney | Translocator protein ligands |
EP2103614A1 (de) * | 2008-03-18 | 2009-09-23 | Santhera Pharmaceuticals (Schweiz) AG | Substituiertes Imidazopyrimidin, Imidazopyrazin und Imidazopyridazinderivate als Melanocortin-4-Rezeptormodulatoren |
AU2009249186B2 (en) * | 2008-05-19 | 2014-05-22 | Sunovion Pharmaceuticals Inc. | Imidazo [1, 2-a] pyridine compounds as GABA-A receptor modulators |
EP2297133B1 (de) | 2008-06-25 | 2017-09-13 | Forum Pharmaceuticals Inc. | 1,2-disubstituierte heterocyclische verbindungen |
US20100267730A1 (en) * | 2008-10-09 | 2010-10-21 | Giuseppe Alvaro | Novel compounds |
DK2427454T3 (da) * | 2009-05-07 | 2013-06-17 | Envivo Pharmaceuticals Inc | Heterocykliske phenoxymethylforbindelser |
TWI617559B (zh) * | 2010-12-22 | 2018-03-11 | 江蘇恆瑞醫藥股份有限公司 | 2-芳基咪唑并[1,2-b]嗒.2-苯基咪唑并[1,2-a]吡啶,和2-苯基咪唑并[1,2-a]吡衍生物 |
UA112028C2 (uk) * | 2012-12-14 | 2016-07-11 | Пфайзер Лімітед | Похідні імідазопіридазину як модулятори гамка-рецептора |
GB201321734D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2492382A1 (fr) * | 1980-10-22 | 1982-04-23 | Synthelabo | Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique |
DE3542661A1 (de) * | 1985-12-03 | 1987-06-04 | Bayer Ag | Imidazopyridazinalkensaeureamide, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung |
DE8808030U1 (de) * | 1987-07-04 | 1988-11-03 | Krones Ag Hermann Kronseder Maschinenfabrik, 8402 Neutraubling | Etikettiervorrichtung für Behälter |
WO1989001333A1 (en) * | 1987-08-07 | 1989-02-23 | The Australian National University | IMIDAZO[1,2-b]PYRIDAZINES |
CA2285264A1 (en) * | 1997-04-25 | 1998-11-05 | Michiyo Gyoten | Condensed pyridazine derivatives, their production and use |
US6303597B1 (en) * | 1998-01-14 | 2001-10-16 | Merck Sharp & Dohme Limited | Triazolo-pyridazine derivatives as ligands for GABA receptors |
WO2000023450A1 (fr) * | 1998-10-21 | 2000-04-27 | Takeda Chemical Industries, Ltd. | Derives fusionnes de pyridazine, procede de preparation correspondant et utilisation de ces derives |
PL355206A1 (en) * | 1999-10-08 | 2004-04-05 | Grunenthal Gmbh | Bicyclic imidazo-3-yl-amine derivatives |
CA2390919A1 (en) * | 1999-11-11 | 2001-05-17 | Takeda Chemical Industries, Ltd. | Nose drop containing condensed pyridazine |
JP2002371042A (ja) * | 2001-06-12 | 2002-12-26 | Takeda Chem Ind Ltd | ジアミン化合物、その製造法および用途 |
BR0308243B1 (pt) * | 2002-03-05 | 2014-08-26 | Lilly Co Eli | Derivados de purina como inibidores de quinase, seu uso para tratar diabetes e doença de alzheimer, para estimular deposição óssea e inibir gsk-3, bem como formulação farmacêutica compreendendo os referidos derivados |
GB0210124D0 (en) * | 2002-05-02 | 2002-06-12 | Merck Sharp & Dohme | Therapeutic agents |
CA2509561A1 (en) * | 2002-12-18 | 2004-07-15 | Mallinckrodt Inc. | Synthesis of heteroaryl acetamides |
ES2222813B1 (es) * | 2003-07-24 | 2005-12-16 | Ferrer Internacional, S.A. | N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados. |
EP1814880B1 (de) * | 2004-11-11 | 2009-01-28 | Ferrer Internacional, S.A. | Imidazo[1,2-a]pyridinverbindungen, zusammensetzungen, anwendungen und verfahren, die damit in zusammenhang stehen |
WO2006083682A2 (en) * | 2005-01-28 | 2006-08-10 | H.Lundbeck A/S | Polymorphic forms of a gabaa agonist |
EP1803722A1 (de) * | 2006-01-03 | 2007-07-04 | Ferrer Internacional, S.A. | Imidazo[1,2-a]pyridin-3-yl-Essigsäure-Hydrazide, Verfahren zur ihrer Herstellung und ihre Verwendung als Arzneimittel |
WO2008052733A1 (en) * | 2006-10-30 | 2008-05-08 | Novartis Ag | Imidazopyridazines as pi3k lipid kinase inhibitors |
-
2006
- 2006-03-29 EP EP06111899A patent/EP1845098A1/de not_active Withdrawn
-
2007
- 2007-03-28 DE DE602007007203T patent/DE602007007203D1/de active Active
- 2007-03-28 CN CN2007800178464A patent/CN101448831B/zh not_active Expired - Fee Related
- 2007-03-28 WO PCT/EP2007/052988 patent/WO2007110437A1/en active Application Filing
- 2007-03-28 KR KR1020087026124A patent/KR20090008275A/ko not_active Application Discontinuation
- 2007-03-28 SI SI200730332T patent/SI2010536T1/sl unknown
- 2007-03-28 AU AU2007231362A patent/AU2007231362B2/en not_active Ceased
- 2007-03-28 AT AT07727460T patent/ATE471325T1/de active
- 2007-03-28 RU RU2008142841/04A patent/RU2486188C9/ru not_active IP Right Cessation
- 2007-03-28 EP EP07727460A patent/EP2010536B1/de not_active Not-in-force
- 2007-03-28 PL PL07727460T patent/PL2010536T3/pl unknown
- 2007-03-28 DK DK07727460.3T patent/DK2010536T3/da active
- 2007-03-28 ES ES07727460T patent/ES2347182T3/es active Active
- 2007-03-28 JP JP2009502081A patent/JP5091944B2/ja not_active Expired - Fee Related
- 2007-03-28 MX MX2008012274A patent/MX2008012274A/es active IP Right Grant
- 2007-03-28 US US12/225,740 patent/US8153789B2/en not_active Expired - Fee Related
- 2007-03-28 CA CA2647116A patent/CA2647116C/en not_active Expired - Fee Related
- 2007-03-28 PT PT07727460T patent/PT2010536E/pt unknown
- 2007-03-28 WO PCT/EP2007/052989 patent/WO2007110438A1/en active Application Filing
- 2007-03-28 BR BRPI0709207-5A patent/BRPI0709207A2/pt not_active IP Right Cessation
- 2007-03-29 AR ARP070101320A patent/AR060212A1/es unknown
- 2007-03-29 TW TW096111150A patent/TWI403512B/zh not_active IP Right Cessation
-
2008
- 2008-10-17 NO NO20084375A patent/NO20084375L/no not_active Application Discontinuation
-
2009
- 2009-06-03 HK HK09104968.1A patent/HK1127917A1/xx not_active IP Right Cessation
-
2010
- 2010-09-13 CY CY20101100829T patent/CY1111211T1/el unknown
-
2011
- 2011-10-27 US US13/282,926 patent/US8993562B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1127917A1 (en) | Imidazo [1,2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands | |
ZA200909186B (en) | 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives,preparation thereof and therapeutic use thereof | |
ZA201001214B (en) | 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapuetic application thereof | |
SI2069342T1 (sl) | Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba | |
ZA201004524B (en) | Pyrido[2,3-b]pyrazine-8-substituted compounds and their use | |
EP2387315A4 (de) | Imidazo-[1,2-a-]pyridine und imidazo-[1,2-b-]pyridazine als mark-hemmer | |
IL194522A0 (en) | Process for the preparation of prasugrel | |
IL193740A0 (en) | PYRIDO [3, 2 - e] PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM | |
IL201471A0 (en) | Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof | |
IL219424A0 (en) | IMIDAZO [1,2-b] PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS | |
IL201450A0 (en) | Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof | |
IL211141A0 (en) | 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof, and therapeutic application thereof | |
IL206673A0 (en) | Imidazo[1,2-a]pyridine-2-carboxamide derivatives, their preparation and their therapeutic application | |
PL2448940T3 (pl) | Pochodne 6,7,8,9-tetrahydro-pirymido{1,2-a} pirymidyn-4-onu, ich wytwarzanie i zastosowanie farmaceutyczne | |
HK1138581A1 (en) | Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands | |
IL206671A0 (en) | N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
IL197500A0 (en) | Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof | |
IL195949A0 (en) | Use of derivatives of imidazo[1,2-a]pyridine-2-carboxamides in therapeutics | |
IL213581A0 (en) | Derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo [1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo [1,2-b]-pyridazine, preparation and therapeutic application thereof | |
IL213208A0 (en) | 6-cycloamino-3-(1h-pyrrolo[2,3-b]pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof | |
IL206669A0 (en) | 6-HETEROCYCLIC IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | |
IL187441A0 (en) | Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid | |
ZA201004520B (en) | N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds,preparation thereof and therapeutic application thereof | |
IL198689A0 (en) | Pyrrolo [1,2-a] imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotheraupeutic agents | |
SI2059521T1 (sl) | Pirazolo alfa pirimidini postopki uporabe in sestavki |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170328 |